Literature DB >> 33773161

Systemic immune-inflammation index and incident cardiovascular diseases among middle-aged and elderly Chinese adults: The Dongfeng-Tongji cohort study.

Man Xu1, Ruoling Chen2, Li Liu3, Xuezhen Liu4, Jian Hou5, Jiaqiang Liao4, Ping Zhang6, Jiao Huang3, Li Lu7, Long Chen8, Mengran Fan4, Xiuyi Chen4, Xiaofan Zhu4, Bing Liu9, Ping Hu10.   

Abstract

BACKGROUND AND AIMS: Systemic immune-inflammation index (SII) has been recently investigated as a novel inflammatory and prognostic marker. SII may be used as an indicator reflecting the progressive inflammatory process in atherosclerosis, although its link to incident cardiovascular disease (CVD) has not been examined in previous studies. This study aims to prospectively assess the association of SII with incident CVD and its main subtypes in Chinese adults.
METHODS: Using data from the Dongfeng-Tongji cohort study, 13,929 middle-aged and older adults with a mean age of 62.56 years (range 35-91 years), who were free of CVD and cancer, were included for analysis. The baseline study was conducted in Shiyan city, Hubei province from 2008 to 2009. The SII was calculated as platelet count (/L) × neutrophil count (/L)/lymphocyte count (/L). Cox regression models were used to examine the associations of SII with incident CVD, including stroke and coronary heart disease (CHD).
RESULTS: Over a median 8.28 years (maximum 8.98 years) of follow-up, 3386 total CVD cases, including 801 stroke cases and 2585 total CHD cases, were identified. In multivariable Cox regression analyses, higher levels of log-transformed SII were significantly associated with total stroke (HR 1.224, 95% CI 1.065-1.407) and ischemic stroke (HR 1.234, 95% CI 1.055-1.442). For those participants with the highest quartiles of SII versus the lowest quartiles of SII, the HRs were 1.358 (95% CI 1.112-1.658) for total stroke, 1.302 (95% CI 1.041-1.629) for ischemic stroke, and 1.600 (95% CI 1.029-2.490) for hemorrhagic stroke.
CONCLUSIONS: SII may serve as a useful marker to elucidate the role of the interaction of thrombocytosis, inflammation, and immunity in the development of cerebrovascular diseases in the middle-aged and elderly population.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cardiovascular diseases; Coronary heart disease; Risk; Stroke; Systemic immune-inflammation index

Year:  2021        PMID: 33773161     DOI: 10.1016/j.atherosclerosis.2021.02.012

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  12 in total

1.  Systemic immune-inflammation index as a novel predictor of atrial fibrillation after off-pump coronary artery bypass grafting.

Authors:  Dursun Topal; Ufuk Turan Kursat Korkmaz; Yusuf Velioglu; Ahmet Yuksel; Ibrahim Donmez; Erhan Renan Uçaroğlu; Seyit Ali Kayis
Journal:  Rev Assoc Med Bras (1992)       Date:  2022-09       Impact factor: 1.712

2.  Inhibitory Effect of Lactobacillus delbrueckii subsp. bulgaricus KSFY07 on Kappa-Carrageenan-Induced Thrombosis in Mice and the Regulation of Oxidative Damage.

Authors:  Pan Wang; Fang Tan; Jianfei Mu; Hongjiang Chen; Xin Zhao; Yanan Xu
Journal:  Cardiovasc Ther       Date:  2022-06-15       Impact factor: 3.368

3.  Association of Dietary Inflammatory Potential with Blood Inflammation: The Prospective Markers on Mild Cognitive Impairment.

Authors:  Xuan Wang; Tiantian Li; Hongrui Li; Dajun Li; Xianyun Wang; Ai Zhao; Wannian Liang; Rong Xiao; Yuandi Xi
Journal:  Nutrients       Date:  2022-06-10       Impact factor: 6.706

4.  Association of inflammatory markers with cerebral small vessel disease in community-based population.

Authors:  Lingling Jiang; Xueli Cai; Dongxiao Yao; Jing Jing; Lerong Mei; Yingying Yang; Shan Li; Aoming Jin; Xia Meng; Hao Li; Tiemin Wei; Yongjun Wang; Yuesong Pan; Yilong Wang
Journal:  J Neuroinflammation       Date:  2022-05-06       Impact factor: 9.587

Review 5.  Factors Determining Plasticity of Responses to Drugs.

Authors:  Michael J Parnham; Jennifer A Kricker
Journal:  Int J Mol Sci       Date:  2022-02-13       Impact factor: 5.923

6.  Value of the Systemic Immune-Inflammatory Index (SII) in Predicting the Prognosis of Patients With Peripartum Cardiomyopathy.

Authors:  Yuan Zhang; Wenzhao Liu; Huaitao Yu; Zhen Chen; Chunmei Zhang; Yun Ti; Peili Bu
Journal:  Front Cardiovasc Med       Date:  2022-02-17

7.  Lactobacillus plantarum HFY05 Attenuates Carrageenan-Induced Thrombosis in Mice by Regulating NF-κB Pathway-Associated Inflammatory Responses.

Authors:  Shi Zeng; Ruokun Yi; Fang Tan; Peng Sun; Qiang Cheng; Xin Zhao
Journal:  Front Nutr       Date:  2022-03-04

8.  Systemic immune-inflammation index as a potential biomarker of cardiovascular diseases: A systematic review and meta-analysis.

Authors:  Zhen Ye; Tingyi Hu; Jin Wang; Ruoyi Xiao; Xibei Liao; Mengsi Liu; Zhen Sun
Journal:  Front Cardiovasc Med       Date:  2022-08-08

9.  Relationship between Systemic Immune-Inflammation Index and Coronary Collateral Circulation in Patients with Chronic Total Occlusion.

Authors:  Mehmet Koray Adali; Ipek Buber; Gursel Sen; Samet Yilmaz
Journal:  Arq Bras Cardiol       Date:  2022-07       Impact factor: 2.667

10.  Prognostic Value of Systemic Immune-Inflammation Index among Critically Ill Patients with Acute Kidney Injury: A Retrospective Cohort Study.

Authors:  Lan Jia; Chen Li; Xueqing Bi; Fang Wei; Jia Meng; Guijiang Sun; Haibo Yu; Hongye Dong; Bo Li; Yueqi Cao; Lihua Wang; Aili Jiang
Journal:  J Clin Med       Date:  2022-07-08       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.